CLINICAL TRIAL COMPLIANCE & OPERATIONS TECHNOLOGY INSIGHTS
-
What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't
During a Society for Clinical Data Management (SCDM) panel discussion, three site-side representatives discussed the challenges clinical research coordinators have executing their clinical duties amid increasingly complex data entry demands.
-
SCDM 2025: Practical Advice From Global Regulators — Including The FDA
Discover what regulators from around the world, including the FDA, think should be top of mind for clinical data managers.
IRT RESOURCES
-
Unearth how modern software development in clinical research technology will shape the industry's future.
-
Explore several elements of modern software development concepts and how they’re transforming interactive response technology platforms and user experiences.
-
As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
RBQM RESOURCES
-
The industry anticipates a transformative shift towards embedding RBQM as a foundational practice in modern clinical research as a means to enhance trial efficiency and safety.
-
Clinical data innovators prioritize risk-based quality management, standards, and closer collaboration with research sites. Many see AI as an important support rather than a top priority.
-
Explore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.
RTSM RESOURCES
-
As clinical trials grow in complexity, discover how adopting adaptive, unified RTSM technology can help to reduce costs and maintain accurate, real-time study data.
-
As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
EREG RESOURCES
-
Centralized eSource systems enable complex clinical trials to align with key regulatory frameworks, including ICH E6(R3), ICH E8(R1), and 21 CFR 312, to meet the highest standards of GCP.
-
Explore the critical process of Study Start-Up (SSU) in clinical trials, with an emphasis on the collaborative efforts of sponsors and research sites to enhance efficiency and reduce timelines.
-
Electronic clinician-reported outcomes (eClinROs) enhance the quality and consistency of clinical trial data. Discover key factors to consider when selecting an eClinRO provider.
PAYMENT RESOURCES
-
Discover how a specialized site payment solution can streamline your clinical trials, enhance site engagement, and deliver measurable financial benefits.
-
Seasoned clinical research expert and advocate of data ethics Angela Radcliffe discusses how the industry can enhance the lives of both patients and clinical trial sites.
-
Discover how Greenphire's innovative payment solutions can transform your clinical trial operations and ensure site sustainability.
IRT SOLUTIONS
RBQM SOLUTIONS
RTSM SOLUTIONS
EREG SOLUTIONS
-
Hassan Khalid of AstraZeneca and Jessica Jolly, a senior data and science executive, talk about the advantages of automation as a result of a Guidance like ICH M11, and why “automation” is not synonymous with AI in this case.
-
Jessica Jolly, a senior data and science executive, is challenging CDOs (chief data officers) and CDAOs (chief data & analytics officers) to stop putting the data science community “to sleep” with the traditional monotonous SOPs, and instead, move more toward autonomous governance by design.
-
Take advantage of this checklist for evaluating eRegulatory solutions for clinical trial offices.
PAYMENT SOLUTIONS
-
Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas.
-
Enhance your Clinical Trial Payments solution with IQVIA Forecasting to leverage our global expertise and navigate the complexities of payments with ease.
-
In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before.